BioWorld: Obesity Report : Tipping the Market Scales with Biotech & Med-Tech Regimens

May 26, 2010Media coverage

BioWorld & Medical Device Daily BioVista Inc. has drugs in various stages of research and preclinical development for eye disorders, diabetes and obesity. According to its website, the Charlottesville, Va.-based company has identified four novel targets involved in diabetes and obesity that lend them- selves to the development of RNAi drugs. Using artificial intelligence (AI), … Read More